Abridge names chief technology officer

Giles Bruce / beckershospitalreview - San Oo has been named chief technology officer of healthcare AI startup Abridge. Mr. Oo was most recently senior vice president of engineering at AI workspace developer Notion. He previously cofounded two tech companies that were acquired by LinkedIn and …

AI Summary: Abridge has appointed a new chief technology officer to lead its product and engineering strategy, signaling a push to scale its clinical AI tools and platform capabilities. The hire aims to strengthen technical leadership, accelerate development timelines, and reassure customers that the company intends to keep up with the fast-paced demands of healthcare AI — which, ironically, keeps hiring to stop churn.


AI startups scale via health system partnerships


Practical challenges: accessibility, training, oversight of clinical AI

6 wks / oncodaily

6 wks / oncodaily


All Other Stories

6 wks / oncodaily





Related Stories


AdaptHealth discloses social-engineering cyberattack compromising data / 11 hrs

Beth Israel Lahey launches systemwide AI scribe with executive lead / 2 months

CVS Health and Google Cloud partner on AI-powered engagement platform / 4 months

Optum unveils Value Connect AI platform to support value-based care / 4 months

Solace Health raises $130M, reaches unicorn valuation with advocacy model / 4 months

Epic unveils built–in AI charting tool to transform clinical documentation / 5 months

Pearl Health raises $110M to scale Medicare provider technology / 11 hrs

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Gene Therapy, CDC, Long COVID, Medical Devices and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.